7,659 Shares in Inspire Medical Systems, Inc. $INSP Bought by Landscape Capital Management L.L.C.

Key Points

• Landscape Capital Management L.L.C. acquired a new position in Inspire Medical Systems, purchasing 7,659 shares valued at approximately $1.22 million during the first quarter.
• Inspire Medical Systems reported EPS of $0.45 for the quarter, beating analyst predictions, and has set its FY 2025 guidance at 0.400-0.500 EPS.
• The company approved a $200 million share repurchase program, indicating management's belief that the stock is undervalued, while 94.91% of the stock is held by institutional investors.

Landscape Capital Management L.L.C. acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,659 shares of the company's stock, valued at approximately $1,220,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. Parallel Advisors LLC lifted its position in Inspire Medical Systems by 356.5% during the first quarter. Parallel Advisors LLC now owns 210 shares of the company's stock worth $33,000 after buying an additional 164 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in Inspire Medical Systems by 27.2% during the first quarter. Smartleaf Asset Management LLC now owns 454 shares of the company's stock worth $71,000 after buying an additional 97 shares in the last quarter. GAMMA Investing LLC lifted its position in Inspire Medical Systems by 253.7% during the first quarter. GAMMA Investing LLC now owns 573 shares of the company's stock worth $91,000 after buying an additional 411 shares in the last quarter. Archer Investment Corp purchased a new position in Inspire Medical Systems during the first quarter worth approximately $96,000. Finally, AlphaQuest LLC lifted its position in Inspire Medical Systems by 248.5% during the first quarter. AlphaQuest LLC now owns 1,028 shares of the company's stock worth $164,000 after buying an additional 733 shares in the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Lake Street Capital set a $150.00 price objective on Inspire Medical Systems and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Morgan Stanley reduced their target price on Inspire Medical Systems from $200.00 to $182.00 and set an "overweight" rating on the stock in a research report on Tuesday, July 15th. Robert W. Baird lifted their target price on Inspire Medical Systems from $230.00 to $236.00 and gave the company an "outperform" rating in a research report on Tuesday, May 6th. Piper Sandler reduced their target price on Inspire Medical Systems from $233.00 to $150.00 and set an "overweight" rating on the stock in a research report on Tuesday, August 5th. Finally, Evercore ISI started coverage on Inspire Medical Systems in a research report on Tuesday. They issued an "outperform" rating and a $150.00 target price on the stock. Eight analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $164.50.

Inspire Medical Systems Price Performance

Shares of INSP stock traded up $0.83 on Tuesday, hitting $94.52. The stock had a trading volume of 824,467 shares, compared to its average volume of 688,613. The firm has a market capitalization of $2.79 billion, a P/E ratio of 54.64, a P/E/G ratio of 2.92 and a beta of 1.15. Inspire Medical Systems, Inc. has a 1 year low of $73.92 and a 1 year high of $225.00. The company's 50 day moving average price is $113.14 and its 200-day moving average price is $140.38.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings data on Monday, August 4th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.23. The firm had revenue of $217.09 million for the quarter, compared to the consensus estimate of $214.50 million. Inspire Medical Systems had a return on equity of 10.38% and a net margin of 6.17%.The company's quarterly revenue was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.32 EPS. Inspire Medical Systems has set its FY 2025 guidance at 0.400-0.500 EPS. On average, equities analysts forecast that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Inspire Medical Systems declared that its board has approved a stock buyback program on Monday, August 11th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the company to repurchase up to 8.6% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its stock is undervalued.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.